Johnson & Johnson
Pharmaceutical / Medical Devices / HealthcareFounded 1886- Updated June 2026
Reviewed by Swet Parvadiya
Last reviewed: June 2026
CorpDigest
Johnson & Johnson
Annual Revenue
Last reviewed: 2026-06-03 · By Swet Parvadiya
FY2021 Revenue
$93.8B
▲ 13.6% vs FY2020 ($82.6B)
Johnson & Johnson reported $93.8B in revenue for fiscal year 2021. This represents a growth of 13.6% compared to the 2020 figure of $82.6B. In 2022, revenue declined to $93.8B.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2024 | $88.8B | $13.3B | +4.3% |
| FY2023 | $85.2B | — | -9.2% |
| FY2022 | $93.8B | — | +0.0% |
| FY2021 | $93.8B | — | +13.6% |
| FY2020 | $82.6B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.